Antibiotic drip showdown: continuous vs. intermittent for bone infections
NCT ID NCT03246360
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at two different ways of giving the antibiotic cloxacillin to treat bone and joint infections caused by Staphylococcus aureus bacteria. Twelve patients received the drug both as a steady drip (continuous infusion) and as short doses (intermittent infusion) to see if the amount of drug in the blood was similar. The goal was to find out if one method works as well as the other, not to test a new cure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLOXACILLIN TREATMENT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de Nice
Nice, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Aging in place: could mobile teams keep nursing home residents out of the hospital?
- A pillow shaped to protect the spine after surgery — a small trial puts it to the test
- Drone Warfare's hidden toll: new study tracks infection risk in combat wounds
- Rapid molecular tests could help doctors prescribe antibiotics more precisely
- Do future doctors know the skin risks of tattoos and piercings?
- Genetic test could shorten hospital stays for fungal infection patients